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BIOCOMPATIBLE, BIODEGRADABLE 
POLYMER-BASED, LIGHTER THAN OR 
LIGHT AS WATER SCAFFOLDS FOR TISSUE 
ENGINEERING AND METHODS FOR 
PREPARATION AND USE THEREOF 
This patent application is a continuation of U.S. patent 
application Ser. No. 10/052,121 filed Jan. 17, 2002 now aban-
doned which claims the benefit of priority from U.S. Provi-
sional Application Ser. No. 60/262,128 filed Jan. 17, 2001, 
teachings of each of which are hereby incorporated by refer-
ence in their entirety. 
This invention was supported in part by funds from the U. S. 
government (NASA Grant No. NAG 9-832 and NIH Grant 
No. AR07132-23) and the U.S. government has certain rights 
in the invention. 
FIELD OF THE INVENTION 
The present invention relates to scaffolds for tissue engi-
neering specifically designed for cell culture in vitro in a 
rotating bioreactor. Scaffolds of the present invention com-
prise biocompatible, biodegradable polymer-based microcar-
riers which are lighter than and/or light as water. In a preferred 
embodiment, the biocompatible, biodegradable, lighter than 
or light as water microcarriers are bonded into a scaffold 
which is then cultured with cells in a rotating bioreactor. 
Methods for preparation and use of these scaffolds as tissue 
engineering devices are also provided. 
BACKGROUND OF THE INVENTION 
In 1993, Langer and Vacanti et al. estimated the number of 
bone repair procedures performed in the United States at over 
800,000 per year (Science 1993 260(5110):920-926). Today, 
skeletal reconstruction has become an increasingly common 
and important procedure for the orthopaedic surgeon. Con-
ventional approaches in bone repair have involved biological 
grafts such as autogenous bone or autografts, allogenic bone 
or allografts and xenografts (Burwell, R. G. History of bone 
grafting and bone substitutes with special reference to osteo-
genic induction, in Bon Grafts, Derivatives and Substitutes., 
M. R. Urist and R. G. Burwell, Editors. 1994, Butterworth-
Heinemann Ltd.: Oxford. p. 3). Currently, autograft is the 
preferred biological graft most often utilized in the clinical 
setting, having success rates as high as 80-90% and no risk of 
immune rejection or disease transfer (Cook et al. J. Bone Joint 
Surg. Am. 1994 76(6):827). However, due to limited avail-
ability of autografts and risks of donor site morbidity, alter-
native approaches to bone repair have been sought. 
Numerous tissue engineering solutions have been pro-
posed to address the need for new bone graft substitutes. 
One potentially successful repair solution seeks to mimic 
the success of autografts by removing cells from the patient 
by biopsy and growing sufficient quantities of mineralized 
tissue invitro on implantable, three-dimensional scaffolds for 
use as a functionally equivalent autogenous bone tissue. In 
this way, an ideal bony repair environment is created by 
reproducing the intrinsic properties of autogenous bone mate-
rial, which include: a porous, three-dimensional architecture 
allowing osteoblast, osteoprogenitor cell migration and graft 
re-vascularization; the ability to be incorporated into the sur-
rounding host bone and to continue the normal bone remod-
eling processes; and the delivery of bone forming cells and 
osteogenic growth factors to accelerate healing and differen-
tiation of local osteoprogenitor cells (Burwell, R. G. History 
of bone grafting and bone substitutes with special reference to 
2 
osteogenic induction, in Bone Grafts, Derivatives and Sub-
stitutes., M. R. Urist and R. G. Burwell, Editors. 1994, But-
terworth-Heinemann Ltd.: 5 Oxford, p. 3; Gadzag et al. J. 
Amer. Acad. Ortho. Surg. 1995 3 (1): 1). 
5 	 Biodegradable scaffolds for in vitro bone engineering, 
which possess a suitable three-dimensional environment for 
the cell function together with the capacity for gradual resorp-
tion and replacement by host bone tissue have also been 
described. See, e.g. Casse-bette et al. Calcified Tissue Inter- 
io national 1990 46(1):46-56; Masi et al. Calcified Tissue Inter-
national 1992 51(3):202-212; Rattner et al. In Vitro Cellular 
& Developmental Biology-Animal 1997 33(10):757-762; 
Mizuno et al. Bone 1997 20(2):101-107; El-Ghannam et al. J. 
Biomed. Mater. Res. 1995 29(3):359-370; Ducheyne et al. J. 
15 Cell. Biochem. 1994 56(2):162-167; Ishaug et al. J. Biomed. 
Mater. Res. 1997 36(1):17-28; Ishuag-Riley et al. Biomate-
rials 20199819(15):1405-1412; Goldstein et al. Tissue Engi-
neering 1999 5 (5): 421-433; Devin et al. J. Biomater. Sci-
ence-Polymer Edition 1996 7(8):661-669; Laurencin et al. 
20 Bone 199619(1):593-599; Thomson et al. Biomaterials 1998 
19(21):1935-1943; and Laurencin et al. J. Biomed. Mater. 2 5 
Res. 1996 30(2):133-138. This three-dimensional matrix 
milieu provides the necessary microenvironment for cell-cell 
and cell-matrix interaction, and is sufficient for the produc- 
25 tion of limited amounts of mineralized bone matrix in static 
culture. To demonstrate clinical feasibility of tissue engi-
neered bone and to sufficiently match the intrinsic properties 
of autogenous bone graft material, however, rapid mineral-
ization of osteoid tissue grown in vitro must be achieved. In 
30 the above-described three-dimensional matrices, nonhomo-
geneous cell seeding 35 confines cell density to the near 
surface of the scaffold and mineralized tissue formation is 
limited by inadequate diffusion of oxygen, nutrients, and 
waste. 
35 	 Using porous polylactic glycolic acid (PLAGA) foams 
with pore sizes ranging from 150 to 710 µm, Ishaug-Riley et 
al. (Biomaterials 1998 19(15):1405-1412) have observed a 
limit to osseous tissue ingrowth and mineralization in a static 
culture environment of about 200 µm. While it is possible that 
40 structures with larger pores would facilitate greater diffusion, 
important cell-cell interactions and scaffold mechanical 
integrity could be compromised. 
Formation of three-dimensional assemblies for culturing 
of various cell types in a rotating bioreactor have been 
45 described. See e.g. Goldstein et al. Tissue Engineering 1999 
5(5):421-433; Granet et al. Cell Eng. 1998 36(4):513-519; 
Klement et al. J. Cellular Biochem. 1993 51(3):252-256; Qui 
et al. Tissue Engineering 1998 4(1):19-34; Lewis et al. J. 
Cellular Biochem. 1993 51(3):265-273; Becker et al. J. Cel- 
50 lular Biochem. 1993 51(3):283-289; and Prewett et al. J. 
Tissue Culture Methods 1993 15:29-36. Using such assem-
blies, it has been shown that osteoblast-like MC3T3 cells 
form cell aggregates when grown on non-degradable micro-
spheres and produce collagen fibrils in the matrix between 
55 microspheres (Klement et al. J. Cellular Biochem. 1993 
51(3):252-256). Also, rat stromal cells cultured for 2 weeks 
on cytodex-3 beads formed aggregates, began synthesizing 
mineralized matrix and showed elevated expression of type I 
collagen and osteopontin (Qui et al. Tissue Engineering 1998 
6o 4(1):19-34). However, when microspheres with greater den-
sity than the surrounding medium are placed in a rotating 
bioreactor, centrifugal force induces heavier-than-water 
microspheres to move outward and collide with the bioreactor 
wall. These collisions induce cell damage and are a confound- 
65 ing variable in tissue engineering. 
In the present invention, lighter than or light as water, 
biocompatible, biodegradable microcarriers and scaffolds 
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comprising these microcarriers are used in a three-dimen-
sional culturing method for the growth of mineralized tissues 
in vitro in a rotating bioreactor. The combination of three-
dimensionality and fluid flow of the present invention circum-
vents limitations associated with static three-dimensional 
culturing methods, eliminates confounding wall collisions, 
and increases the rate and extent of mineralized tissue fonna-
tion in the rotating bioreactor. Scaffolds prepared in accor-
dance with the present invention exhibit controllable and 
quantifiable motion in a bioreactor environment, thereby 
enhancing fluid transport throughout the scaffold. As demon-
strated herein, scaffolds produced in accordance with the 
present invention support cell attachment, growth, and phe-
notypic expression over short-term culture ultimately result-
ing in enhanced synthesis of mineralized bone graft quality 
tissue. 
SUMMARY OF THE INVENTION 
An object of the present invention is to provide scaffolds 
for tissue engineering comprising biocompatible, biodegrad-
able polymer-based, lighter than or light as water microcar-
riers. In a preferred embodiment, the scaffolds are seeded 
with cells via culturing in vitro in a rotating bioreactor. 
Another object of the present invention is to provide a 
method of producing scaffolds for tissue engineering which 
comprises preparing biocompatible, biodegradable polymer-
based microcarriers which are lighter than or light as water; 
bonding the biocompatible, biodegradable polymer-based 
microcarriers into a scaffold and seeding the scaffold with 
cell via culturing in vitro in a rotating bioreactor. 
Another object of the present invention is to provide meth-
ods forusing scaffolds comprising biocompatible, biodegrad-
able polymer-based, lighter than or light as water microcar-
riers seeded with cells via culturing in vitro in a rotating 
bioreactor as tissue engineering devices. Scaffolds of the 
present invention can be seeded with cells including, but not 
limited to, osteoblast and osteoblast-like cells, endocrine 
cells, fibroblasts, endothelial cells, genitourinary cells, lym-
phatic vessel cells, pancreatic islet cells, hepatocytes, muscle 
cells, intestinal cells, kidney cells, blood vessel cells, thyroid 
cells, parathyroid cells, cells of the adrenal-hypothalamic 
pituitary axis, bile duct cells, ovarian or testicular cells, sali-
vary secretory cells, renal cells, chondrocytes, epithelial cells, 
nerve cells and progenitor cells such as myoblast or stem 
cells, particularly pluripotent stem cells, and used in the 
regeneration of tissues derived from such cells. 
DETAILED DESCRIPTION OF THE INVENTION 
The present invention relates to tissue engineering scaf-
folds and methods for production of tissue engineering scaf-
fold which promote growth in vitro of mineralized bone tissue 
in a rotating bioreactor. To produce these scaffolds, polymer 
microencapsulation methods were adapted for the formation 
of hollow, lighter than or light as water microcarriers of 
biocompatible, biodegradable polymers. Scaffolds were then 
fabricated by sintering together the lighter than or light as 
water microcarriers into a fully interconnected, three dimen-
sional network. The microcarriers and scaffolds of the present 
invention move within the fluid medium of the rotating biore-
actor in a near circular trajectory while avoiding collision 
with the bioreactor wall. Cell culture studies on the scaffolds 
of the present invention show that cells readily attach to 
microcarrier scaffolds. In addition, cells cultured in vitro in a 
rotating bioreactor on these lighter-than-water scaffolds 
retained their phenotype and showed significant increases in 
alkaline phosphatase expression and alizarin red staining by 
day 7 as compared to statically cultured controls. 
By "lighter than or light as water microcarriers" it is meant 
microcarriers with a density equal to or less than water. 
5 It has been shown previously that when osteoblast cells are 
co-inoculated with microcarriers in a rotating bioreactor a 
random aggregation occurs generated by the adherence of 
cells to microcarrier beads and the formation of cellular 
bridges between adjacent microcarriers (Grant et al. Cell 
io Eng. 1998 36(4):513-519; Qiu et al. Tissue Engineering 1998 
4(1):19-34; and Watts et al. Critical Reviews in Therapeutic 
Drug Carrier Systems 1990 7(3):235-259). However, this 
random aggregation that occurs in the rotating bioreactor is 
not conducive to strict quantitative comparison, because the 
15 size and shape of cell-bead aggregates as well as the degree of 
aggregation varies greatly. Such a limitation is overcome by 
the present invention via the sintered pre-assembly of micro-
carriers into dimensionally reproducible cell scaffolds prior 
to culture in the bioreactor. Furthermore, the microcarrier 
20 sintering method of the present invention is not limited by the 
adverse effects associated with the particulate leaching and 
consequently no unwanted degradation of the scaffold occurs 
during fabrication. 
Microcarriers of the present invention which are light than 
25 or light as water exhibit buoyancy after immersion in deion-
ized water, phosphate buffer solution and tissue culture 
medium. In a preferred embodiment, microcarriers of the 
present invention are fabricated to produce lighter than water 
densities from about 0.6 to about 0.99 g/cc as estimated using 
3o a density gradient column (ASTM D-1505). Microcarriers 
with densities as light as water or 1.0 g/cc can also be used. 
Using PLAGA to produce microcarriers of the present, the 
majority of lighter than or light as water microcarriers (47%) 
were within the range of 500 to 860 µm in diameter, with 19% 
35 from 300-500 µm, 8% at 100-300 µm and 2% less than 100 
µm. Though 29% of microcarriers were greater than 860 µm 
in diameter, it is preferred that only microcarriers 860 µm and 
below are used for scaffold fabrication. For bone tissue engi-
neering devices, it is preferred that microcarriers in the size 
4o range of 500-860 µm be used for scaffold fabrication, as they 
form structures with an expected pore size range of 113 to 356 
µm shown to be suitable for osteoblast adherence and migra-
tion (Ishaug-Riley et al. Biomaterials 1998 19(15):1405-
1412; Laurencin et al. Bone 1996 19(1):S93-S99). PLAGA 
45 microcarriers of this size range, when sintered, produce an 
interconnected network with an average pore size of 187 µm 
and aggregate density of 0.65 g/cc. 
While PLAGA has been used as the exemplary microcar-
rier, as will be understood by those of skill in the art upon this 
5o disclosure, other biocompatible, biodegradable polymers can 
be used in the production of scaffolds of the present invention. 
Examples of such polymers include, but are not limited to, 
lactic acid polymers such as poly(L-lactic acid (PLLA), poly 
(DL-lactic acid (PLA), and poly(DL-lactic -co -glycolic acid) 
55 (PLGA). Blends of PLLA with PLGA, can also be used for 
these scaffolds. Other exemplary biodegradable polymers 
useful in the scaffolds of the present invention include, but are 
not limited to, polyorthoesters, polyanhydrides, polyphosp-
hazenes, polycaprolactones, polyhydroxybutyrates, degrad- 
6o able polyurethanes, polyanhydrideco-imides, polypropylene 
fumarates, and polydiaxonane. 
The hollow microcarriers are then fabricated into scaf- 
folds, preferably via sintering in a mold for tissue engineering 
devices at a temperature which promotes bonding of the 
65 microcarriers but is below the melting temperature of the 
polymer. For example, PLAGA microcarriers were fabricated 
into 4 mmx2.5 mm cylindrical scaffolds by sintering at 60° C. 
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At this temperature, amorphous polymer chains of adjacent 	 In experiments with o steoblast-like cells, cell density in the
microcarriers move past one another and inter-lock forming a 	 bioreactor medium decreased about 60%. The decreased con-
mechanical bond. Because this temperature is well below the 	 centration of suspended cells during culture is assumed to
melting temperature, however, collapse of individual micro- 	 reflect the attachment of these cells to the scaffolds. By divid-
carriers is avoided, thereby preserving their hollow, spherical 5 ing the estimated quantity of attached cells by the total num-
geometry and the lighter-than-water density of the aggregate	 ber of scaffolds present in culture, cell seeding was estimated
structure. Porosity is a result of the imperfect packing of 	 to be approximately 1.4x105 cells/scaffold. After 24 hours of
spherical microcarriers inside the mold, and thus geometry	 dynamic seeding, a sampling of 6 to 10 cell-scaffolds was
dictates that there are no isolated spaces (pores) within the 	 used to measure directly the number of cells attached to
structure and that the network of pores in the scaffold is fully io scaffolds using fluorometric DNA analysis. Measurements of
interconnected. The effect of sintering on the connectivity of 	 attached cell were in excellent agreement with cell concen-
microspheres was evident from SEM linkages showing two	 tration estimates with an average value of 1.3x10 5 cells per
or more microspheres fused together at the contact regions.	 scaffold and standard deviation of 2.0x104 cells. The average
Assuming the spheres approach a close packed configuration 	 surface area per scaffold was calculated to be approximately
in the mold, the diameter of the scaffold pores can be repre- 15 2 cm2 resulting in a cell seeding density of approximately
sented as interstitial voids in the structure. Again, geometry 	 6.5x104 cells/cm2.
dictates that the pore of the structure is given by 0.225R in the 	 Cell proliferation was examined on lighter than or light as
case of a tetrahedral site (a void surrounded by 4 spheres in the 	 water microcarrier scaffolds over a period of 7 days with cell
shape of regular tetrahedron) or 0.414R in an octahedral, site 	 numbers measured immediately following cell seeding and at
(a void surrounded by 6 spheres in the shape of an octagon), 20 days 3 and 7. Cells cultured on lighter than or light as water
where R is the radius of the surrounding spheres. 	 scaffolds in the rotating bioreactor show evidence of a lower
The porosity and pore size distribution of typical micro- 	 rate and extent of proliferation than those cultured on non-
carrier scaffolds was measured using mercury porosimetry.	 rotating controls. Significant differences in cell numbers
Although the broad distribution of microcarrier size likely 	 could be detected by day 7 (p<0.05). The presence of cells
decreases the resulting pore diameter and increases packing 25 within the pores of the scaffold that nearly cover the entire
efficiency, the measured porosity of 31 % slightly exceeds that 	 surface of the internal microcarriers was verified by SEM. By
of close packing (26%). The average pore size distribution of 	 progressively focusing the microscope down the pore of the
12 microcarrier scaffolds where the median pore is 187 µm is 	 structure, it was estimated that cells had penetrated as deep as
well within the theoretical expectation for close packed 	 800 µm.
spheres. Although the value median pore diameter exceeds 30	 The retention of osteoblastic phenotype was evaluated by
the minimum requirement for cell ingrowth and migration 	 ALP histochemical staining and calorimetric analysis. Cells
(Ishaug et al. J. Biomed. Mater. Res. 1997 36(1):17-28; 	 were stained for ALP expression on lighter than or light as
Ishaug-Riley et al. Biomaterials 1998 19(15):1405-1412; 	 water scaffolds in the rotating bioreactor and on the non-
Goldstein et al. Tissue Engineering 1999 5(5):421-433; Lau-	 rotating three-dimensional controls at days 3 and 7. Positive
rencin et al. Bone 199619(1): S93 -S99), the level of total pore 35 ALP staining is evident at each time point and for each culture
volume or porosity of microcarrier scaffolds is 50-60% less 	 condition. At each time point, more cells per unit area are
than that of similar polymeric matrices proposed for bone 	 present on scaffolds cultured under non-rotating three-di-
repair (Ishaug et al. J. Biomed. Mater. Res. 1997 36(1):17-28;	 mensional conditions than those cultured in the rotating
Ishaug-Riley et al. Biomaterials 1998 19(15):1405-1412; 	 bioreactor, which is consistent with fluorometric DNA analy-
Goldstein et al. Tissue Engineering 1999 5(5):421-433). 	 40 sis described herein. Calorimetric analysis was also per-
The motion of microcarrier scaffolds constructed primarily 	 formed at 24 hours and at day 7. These results were normal-
from 500 to 860 µm lighter than or light as water microcarri- 	 ized by the actual number of cells present in each scaffold. It
ers and fashioned into 4x2.5 mm cylindrical discs within the 	 was found that by day 7 the actual amount of ALP expressed
rotating bioreactor was assessed. Particle tracking analysis 	 per cell is significantly higher for cells cultured in the rotating
revealed an instantaneous velocity of 98 mm/second and a 45 bioreactor than on non-rotating three-dimensional controls
trajectory completely absent of wall collisions once equilib- 	 (p<0.05).
rium motion was reached. 	 The production of calcified matrix was analyzed by
Cell attachment to microcarrier scaffolds during rotating 	 alizarin red histochemical staining. Scaffolds cultured in the
culture was estimated from cell concentration profiles taken 	 rotating bioreactor showed substantially greater alizarinposi-
at times 4, 8, 12, and 24 hours following co-inoculation with 50 five extracellular matrix material by day 7 as compared to
lighter than or light as water scaffolds. Cells used in these	 three-dimensional controls (p<0.05). To quantify the amount
experiments were osteoblast-like cells. As will be understood	 of early stage calcified matrix formation, alizarin red staining
by those of skill in the art upon reading this disclosure, how- 	 techniques were adapted for calorimetric analysis by solubi-
ever, the scaffolds of the present invention can actually be	 lizing the red matrix precipitate with cetyl pyridinium chlo-
seeded with any cell type which exhibits attachment and 55 ride to yield a purple solution suitable for optical density
ingrowth and is suitable for the intended purpose of the scaf- 	 measurements at 562 nun. Quantities of ALZ stained matrix
fold. Some exemplary cell types which can be seeded into 	 were expressed as a molar equivalent CaCl2 concentration
these scaffolds include, but are not limited to, osteoblast and 	 and normalized by the average number of cells per scaffold as
osteoblast-like cells, endocrine cells, fibroblasts, endothelial
	
determined in companion proliferation studies. Significant
cells, genitourinary cells, lymphatic vessel cells, pancreatic 60 increases in the quantity of ALZ stained matrix produced on
islet cells, hepatocytes, muscle cells, intestinal cells, kidney 	 lighter than or light as water scaffolds under rotating condi-
cells, blood vessel cells, thyroid cells, parathyroid cells, cells 	 tions at days 3 and 7 as compared to non-rotating controls
of the adrenal-hypothalamic pituitary axis, bile duct cells, 	 were observed.
ovarian or testicular cells, salivary secretory cells, renal cells, 	 Thus, as demonstrated herein, lighter than or light as water
chondrocytes, epithelial cells, nerve cells and progenitor cells 65 polymer-basedmicrocapsules are excellent cell microcarriers
such as myoblast or stem cells, particularly pluripotent stem	 providing a low shear, non-turbulent flow environment for
cells.	 attached cells that avoids damaging collisions with the biore-
US 8,137,972 B2 
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actor wall. These scaffolds adopt a particle trajectory absent 
of confounding wall collisions, while maintaining a three-
dimensional geometry open to mass transport of nutrients and 
waste products. In particular, the hydrodynamic flow envi-
ronment produced by the motion of lighter than or light as 5 
water scaffolds in the rotating bioreactor enhances O z and 
nutrient transport to cells at the near surface (external) of the 
scaffold and possibly those in the scaffold interior (internal). 
This may act to advance phenotype development and tissue 
formation in the system of the present invention. Further, cell 10 
seeding of the scaffolds in the rotating bioreactor, as opposed 
to static seeding methods for these scaffolds, enhances cell 
migration to the interior of the scaffold and promotes homo-
geneity of initial cell seeding from one scaffold to another. 
Accordingly, the scaffolds of the present invention provide a 15 
combination of three-dimensionality and fluid transport in the 
absence of damaging wall collisions that appears to be a 
closer approximation of the in vivo environment of the cell 
thereby expanding capacity for ex vivo tissue synthesis. 
Scaffolds of the present invention are expected to particu- 20 
larly useful in developing bone graft quality tissue. However, 
as will be understood by one of skill in the art upon reading 
this disclosure, the method of 
Scaffolds of the present invention are expected to particu-
larly useful in developing bone graft quality tissue. However, 25 
as will be understood by one of skill in the art upon reading 
this disclosure, the method of scaffold fabrication disclosed 
herein can be used to generate a variety of microcarrier scaf-
folds of different component size ranges, associated three-
dimensional architecture, and density useful in a variety of 30 
tissue engineering applications. Scaffolds seeded with cells 
including, but not limited to, osteoblast and osteoblast-like 
cells, endocrine cells, fibroblasts, endothelial cells, genitouri-
nary cells, lymphatic vessel cells, pancreatic islet cells, hepa-
tocytes, muscle cells, intestinal cells, kidney cells, blood ves- 35 
sel cells, thyroid cells, parathyroid cells, cells of the adrenal-
hypothalamic pituitary axis, bile duct cells, ovarian or 
testicular cells, salivary secretory cells, renal cells, chondro-
cytes, epithelial cells, nerve cells and progenitor cells such as 
myoblast or stem cells, particularly pluripotent stem cells, are 40 
useful in the regeneration of tissues derived from such cells. 
The following nonlimiting examples are provided to fur-
ther illustrate the present invention.  
8 
the carriers were indeed hollow. In vitro buoyancy was veri-
fied over 7 days by immersion inside a water-tight container 
maintained at 37° C. in an oscillating (60 opm) water bath. 
Example 2 
Scaffold Fabrication and Characterization 
Microcapsules of a selected size range and weight were 
poured into a stainless steel mold and heated in an oven 
(Precision Gravity Convection Incubator) for 1 hour at 60° C., 
several degrees above the glass transition temperature for the 
PLAGA 50:50 (Tg 45-50° C.). Microcarriers bonded to each 
other while maintaining their hollow, spherical geometry. 
Scaffolds used for bioreactor culture were exposed to ultra-
violet irradiation for 30 minutes on each side in an effort to 
minimize bacterial contamination. Microcarrier scaffolds 
were characterized using a low field emission scanning elec-
tron microscope (SEM, JEOL 6300). For SEM, specimens 
were coated with gold and examined for pore inter-connec-
tivity, degree of microcarrier bonding, and deformation of 
microcarriers. The porosity of the structure was measured by 
porosimetry using the Micromeritics Autopore HI porosim-
eter. Specifically, cylindrical polymer scaffolds, 4 mm in 
diameter and approximately 2.5 mm in length were placed in 
a 5 cc penetrometer, subjected to a vacuum of 50 µm Hg, and 
infused with mercury. Porosity is determined by measuring 
the volume of the mercury infused. In addition to an overall 
percentage of porosity for the polymer scaffold, porosimetry 
will also give an approximate distribution of pore sizes within 
the polymer scaffold, allowing for more accurate character-
ization of the scaffold geometry. 
Example 3 
Numerical Model Simulation and Particle Motion 
Analysis 
The equations of motion governing microcarrier motion in 
the rotating bioreactor are as follows. For the particle position 
(x, y) and velocity (vx, vy), microcapsule motion relative to 
the rotating fluid is governed by equations: 
EXAMPLES 	 45 dx 	 (1) 
Tt =V, 
Example 1 	 d vx 	 1 
	
dt 	 pp". Vpan 
Buoyant Microcarrier Fabrication 
A conventional microsphere fabrication technique was 
adapted for the formation of hollow, lighter than or light as 
water microcarriers of bioerodible poly(d,l-lactic-co-gly-
colide) copolymer. For this technique, a 25% w/v polymer 
solution of 50:50 PLAGA (molecular weight approximately 
30,000) was dissolved in methylene chloride, and poured 
slowly into a 1000 ml beaker containing 0.1% PVA (Poly-
sciences, Lot #413322, molecular weight 25,000). The solu-
tion was stirred continuously (Caframo, Model BDCISSO) at 
1000 rpm for 4 to 6 hours to allow for solvent evaporation. 
Buoyant microcarriers were harvested by vacuum filtration 
(Whatman, 54 µm), washed with deionized water, and lyo-
philized (Lyph-lock 12, Labconco Corp.) for 24 hours. Size 
distribution was determined by mechanically sifting the 
microcarriers using a series of stainless steel sieves with 
selected mesh sizes. Microcarriers were freeze fractured and 
analyzed with scanning electron microscopy to confirm that  
50 	 ~ 	
P'S'Ce'vx+(Pv ~+n—Pflu;e)'Va,.r'1 z -x+ 
dy 
dt 
= Vy 
dvy 	 1 
55 dt =— pp" . VP11 
P'S'Ce'v y +(P,n — P}tu;e)'Va,n'(,)z  'Y - 
2' (Pvan — P.lu;d)' Va,.r w'Y — (Peon — P.lu;d)' Vpa - 8' Cos(mt) 
S= 
60 
Rport 
24 	 6.0 Cd = — + 	 +0.4 
Re 1.0 + Re 
65 
where (p sphe p_ft d) is the difference between the density of 
the microcapsule and surrounding fluid, Re is the Reynolds 
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number, Vp,,,t is the microcarrier volume, C d is the drag coef-
ficient at Re<2x10 5 , p is the stagnation pressure, S is the 
microcapsule planar surface area, and Z is the axis of rotation. 
A numerical solution to these equations was obtained by way 
of a fourth order Runga Kutta integration scheme run on a 
local workstation, using an adaptive stepwise control algo-
rithm to ensure convergence through the integration period 
and assuming a specific starting position (x,y) within the 
bioreactor. Using this numerical model, scaffold parameters 
(e.g. density and drag coefficient) have been identified which 
yield particle trajectories without any confounding wall col-
lisions. Scaffolds were then fabricated from component 
microcarriers which meet these design criteria. 
A particle tracking system built for the rotating bioreactor 
was used to compare resulting scaffold motion in the rotating 
bioreactor relative to the culture medium. The particle track-
ing system is comprised of a rotating CCD camera (Cohn, 
Inc.) that is in synchrony with a rotating High Aspect Ratio 
Vessel (HARV). Particle motions are videotaped (Sony SVO-
9500 MD) and digitally re-recorded using a Sony Frame Code 
Generator and frame grabber (Media Cydernetics). Image 
analysis is carried out using Image Pro (Phase 3 Imaging, 
Inc.). Lighter-than-water PLAGA microcarriers and micro-
carrier scaffolds were incubated in distilled water at room 
temperature for 24 hours in a non-rotating bioreactor vessel 
and their trajectories recorded during bioreactor rotation 
using the tracking apparatus. A temporal description of scaf-
fold trajectory was measured over consecutive frames from 
which particle velocities were computed. From these velocity 
measurements and based on the geometry of the scaffolds 
(and diameter of isolated microcarriers), maximum fluid 
shear stress is estimated by assuming uniform flow past a 
single microcarrier and using the stokes equation: 
-3µU 	 (2) 
- 2a 
where a is shear stress, µ is viscosity, U is flow velocity and a 
is the diameter of the microcarrier. 
Example 4 
Cell Seeding and Culture 
The human SaOS-2 line (ATCC A HTB-85), which exhib-
its homogeneous and reproducible expression of cellular 
alkaline phosphatase over an infinite life span was used. For 
all experiments, cells were maintained in M199 (Gibco) cul-
ture medium supplemented with 10% fetal bovine serum 
(Sigma), 2.5 mM L-glutamine and 3 mM b-glycerol phos-
phate. SaOS-2 cells were grown to confluency and digested in 
0.01% trypsin in 0.04% EDTA (Gibco) for 10 minutes. Cells 
were then resuspended in a minimal amount of media, their 
numbers determined with a Coulter Counter, and diluted to an 
appropriate cell density. Prior to cell seeding, PLAGA scaf-
folds (n=36) were washed in phosphate buffered saline 
(PBS), and placed inside a single bioreactor vessel (Synth-
econ) filled with 55 ml of complete medium containing no 
cells. After 10 minutes, the bioreactor vessel was inoculated 
with 8x10 6 cells and mounted onto a multi-HARV rotating 
unit turning at 25 rpm. Cell attachment to microcarrier scaf-
folds in the rotating vessel was estimated from the decrease of 
cell density in the supernatant fluid observed over 24 hours. 
At time intervals 4, 8, and 12 hours, 0.5 ml of the cell sus-
pension was removed from the bioreactor, re-suspended in 
trypsin solution to dissociate cell aggregates and cell numbers 
were determined using a coulter counter. At 24 hours, the 
entire cell suspension was removed and the cell number deter-
mined. 
5 
Example 5 
Cell Counting 
10 	 Immediately following the seeding of the cells for an 
experiment, a random sampling (n=6 to 10) of selected scaf-
folds was removed and the initial number of attached cells 
were determined by means of a fluorometric DNA assay as 
described by Labarca and Paigen (Anal. Biochem. 1980 102: 
15 344-352). The remaining scaffolds were washed with PBS 
and divided equally into two experimental groups. Each 
group of scaffolds was placed, respectively, into two new 
bioreactor vessels and re-fed with 55 ml of fresh culture 
medium. To determine the effect of culture vessel rotation on 
20 cell function, one vessel was mounted onto a multi-HARV 
unit and rotated at 25 rpm and the other was cultured statically 
(no-rotation) as a control. Each vessel was cultured at 37° C. 
and 5% COz for 7 days. At days 3 and 7, additional scaffolds 
were removed for DNA quantification. Scaffolds used for 
25 DNA analysis were washed 3 times in PBS, combined with 3 
ml of additional PBS containing 2 mM EDTA, and pulverized 
using a tissue homogenizer (PowerGen 35, Fisher) with a 10 
mm diameter saw-tooth generator for 1 minute. Cells were 
ruptured by 2 minutes of further homogenization at 30,000 
30 rpm with a 5 mm diameter flat bottom generator. Homoge-
nates were frozen at -70° C. until the day of analysis. On the 
day of analysis, 1 ml of scaffold homogenate was combined 
with 7 ld of a 200 µg/ml solution of bisbenzimide H33258 dye 
(Calbiochem) and vortexed vigorously. Fluorescence was 
35 read using a Tecan Spectrofluor microplate reader with an 
emission wavelength of 465 nm and an excitation wavelength 
of 360 mu. Cell standards were used to convert measured 
fluorescence to cell numbers, and unseeded but cultured scaf-
folds were analyzed to determine any effect of PLAGA autof- 
40 luorescence. 
Example 6 
Alkaline Phosphatase Activity 
45 
Alkaline Phosphatase (ALP) activity was measured by 
using adaptations of standard histochemical (Van Belle, H. 
Biochimica et Biophysics Acta 1972 289:158-168) and colo-
rimetric (Rattner et al. In Vitro Cellular & Developmental 
5o Biology Animal 1997 33(10):757-762) methods. At days 3 
and 7, scaffolds were removed from both the rotating and 
non-rotating bioreactor vessels and washed two times with 
PBS. Scaffolds were then incubated for 30 minutes at 37° C. 
with Napthol AS-BI (Sigma, N-2250) phosphate salt (0.5 
55 mg/ml; Sigma) and N,N-Dimethyl Formamide (10 µg/ml; 
Sigma D-8654) in 50 mM Tris buffer (pH 9.0), inthepresence 
of Fast Red (Sigma, F-2768) violet salt (1.0 mg/ml). After 30 
minutes, cells were washed two times with PBS and fixed by 
incubation in 2% paraformaldehyde for 30 minutes at 4° C. 
6o ALP staining was viewed by light 5 microscopy. Scaffolds 
were fractured into halves in order to visualize cells in the 
interior regions of the 3-dimensional structure. 
In addition, ALP expression was quantified in each of the 
cell-scaffold homogenates used for fluorometric DNA analy- 
65 sis. For this analysis, aliquots of cell homogenates were incu- 
bated at 37° C. for 30 minutes in 0.1 M Na 2CO3 buffer 
solution (pH 10) containing 2 mM MgCl2  with disodium 
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p-nitrophenyl phosphate (pNP-PO 4) as the substrate. Stan-
dard solutions were prepared by serial dilutions of 0.5 mM
p-nitrophenol (pNP) in Na2CO3 buffer. Enzymatic activity
was expressed as total mmoles of pNP produced per minute
per total cell number determined by fluorometric DNA analy-
sis. Absorbance was measured at 415 nm using a Tecan Spec-
trofluor microplate reader.
Example 7
Alizarin Red Calcium Quantification
The effectiveness of sodium 1,2-dihydroxy anthraquinone-
3-sulfonate, commonly known as Alizarin Red (ALZ), as a
chelating compound and colorometric reagent for spectro-
photometric determination of calcium is well established
(Wu, L. and Forsling, W. Acta Chemica Scandinavica 1992
46:418-422). ALZ spectrophotometric methods were adapted
for the determination of mineralized matrix production (Stan-
ford et al. J. Biol. Chem. 1995 270:9420-9428) on lighter than
or light as water PLAGA by osteoblast-like cells. Scaffolds
were removed from the bioreactor, washed in ddH 20, and
incubated in 40 mM Alizarin red solution (pH 4.2) for 10
minutes at room temperature. To remove unreacted ALZ,
scaffolds were washed 5-10 times in ddH 20 (until water was
clear). Scaffolds were then incubated in 10% cetyl pyri-
dinium chloride for 15 minutes to solubilize reacted ALZ and
pulverized using a tissue homogenizer (PowerGen 35, Fisher)
with a 10 mm diameter saw-tooth generator. Serial dilutions
of 1 N CaC12 were used as standards. ALZ concentration per
cell was calculated as molar equivalent CaCl2 divided by the
average cell number at each time point as determined by
fluorometric DNA analysis. Absorbance was measured at 570
mn using a Tecan Spectrofluor microplate reader.
Example 8
Scanning Electron Microscopy
Before seeding with cells, microcarriers and microcarrier
scaffolds were coated with gold and visualized using a low
field emission electron microscope (JEOL 6300) at 2 keV
accelerating voltage. To evaluate cell attachment and mor-
phology to lighter-than-water scaffolds cultured in the biore-
actor, scaffolds were cultured as described above and
removed at day 7 for SEM analysis. Attached cells were fixed
to scaffold substrates by washing thoroughly with PBS, then
incubation in 1% and 3% glutaraldehyde for 1 hour and 24
hours, respectively. Following fixation, cells were washed
with PBS, placed through a series of graded ethanol dehydra-
tions and allowed to air dry. Finally, cell-scaffolds were
coated with carbon and analyzed at 2 keV.
Example 9
Statistical Analysis
Statistical analysis was performed using JMP IN 3.2.1
software. One-way ANOVA was performed to determine any
statistically significant relationship between the rotating and
non-rotating conditions with respect to the quantity of reacted
ALZ, ALP expression, and cell number. Statistical signifi-
cance was attained at p<0.05. Three scaffolds were analyzed
at each time point and for each quantitative assay.
What is claimed is:
1. A scaffold for tissue engineering comprising a 3-dimen-
sional network of microcarriers, said microcarriers compris-
12
ing at least one biocompatible, biodegradable organic poly-
mer and individually presenting an organic polymer surface
to adjacent microcarriers and having densities less than or
equal to that of water, wherein adjacent microcarriers are
5 fusedto one another at aninterface, eachinterface comprising
a region of direct polymer-polymer contact, and wherein the
3-dimensional network of microcarriers further comprises a
network of interconnected pores.
2. The scaffold of claim 1 further comprising cells.
l0 3. The scaffold of claim 2 wherein the cells comprise
osteoblast cells or cells exhibiting an osteoblastic phenotype,
endocrine cells, fibroblasts, endothelial cells, genitourinary
cells, lymphatic vessel cells, pancreatic islet cells, hepato-
15 cytes, muscle cells, intestinal cells, kidney cells, blood vessel
cells, thyroid cells, parathyroid cells, cells of the adrenal-
hypothalamic pituitary axis, bile duct cells, ovarian ortesticu-
lar cells, salivary secretory cells, renal cells, chondrocytes,
epithelial cells, nerve cells or progenitor cells.
20	 4. The scaffold of claim 1 wherein the microcarriers are
hollow.
5. The scaffold of claim 1 wherein the network of intercon-
nected pores defines a scaffold porosity, and said porosity is
31% of the total volume of the scaffold.
25 6. The scaffold of claim 1 wherein the network of intercon-
nected pores is characterized by a pore size, and the pore size
of the scaffold is in the range of from 113 to 356 microns.
7. The scaffold of claim 1 wherein the biocompatible,
biodegradable polymer comprises a polylactic acid, a poly-
30 orthoester, a polyanhydride, a polyphosphazene, a polycapro-
lactone, a polyhydroxybutyrate, a degradable polyurethane, a
polyanhydrideco-imide, a polypropylene fumarate, or a poly-
diaxonane, or a copolymer or mixture thereof.
8. The scaffold of claim 1 wherein the biocompatible,
35 biodegradable polymer is a polylactic acid polymer or a poly-
lactic acid/polyglycolic acid copolymer or mixture thereof.
9. The scaffold of claim 1 wherein the microcarriers are
microspheres and the diameter of the microspheres is in the
range of 100 to 860 microns.
40 10. The scaffold of claim 1 wherein the microcarriers are
microspheres and the diameter of the microspheres is in the
range of 100 to 500 microns.
11. The scaffold of claim 1 wherein the microcarriers are
microspheres and the diameter of the microspheres is in the
45 range of 300 to 500 microns.
12. The scaffold of claim 1 wherein the microcarriers have
a density in the range of 0.6 to 0.99 gram per cubic centimeter.
13. The scaffold of claim 2 wherein the cells are attached to
the scaffold by seeding, said seeding being achieved via cul-
50 turing in vitro in a rotating bioreactor.
14. The scaffold of claim 3 wherein the cells comprise
osteoblast cells, cells exhibiting an osteoblastic phenotype, or
progenitor cells or mixtures thereof.
15. A method for producing the scaffold of claim 1 com-
55 prising:
(a) preparing microcarriers comprising at least one bio-
compatible, biodegradable organic polymer and pre-
senting an organic polymer surface and which have den-
sities less than or equal to that of water;
60	 (b) organizing the microcarriers so that the polymer sur-
faces of adjacent microcarriers contact one another; and
(c) bonding the biocompatible, biodegradable polymer-
based microcarriers into a scaffold, such that the bond-
ing occurs directly between the organic polymer sur-
65	 faces of adjacent microcarriers.
16. The method of claim 15 wherein the bonding is
achieved by a process comprising heating the microcarriers at
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a temperature above the glass transition temperature but 
below the melting temperature of the biocompatible, biode-
gradable polymers. 
17. A method for regenerating a selected tissue comprising 
seeding the scaffold of claim 1 with cells which generate the 
selected tissue and culturing the scaffold and seeded cells in a 
rotating bioreactor. 
18. The method of claim 17 wherein the seed cells com-
prise seed cells comprise osteoblast and osteoblast-like cells, 
endocrine cells, fibroblasts, endothelial cells, genitourinary 
cells, lymphatic vessel cells, pancreatic islet cells, hepato- 
14 
cytes, muscle cells, intestinal cells, kidney cells, blood vessel 
cells, thyroid cells, parathyroid cells, cells of the adrenal-
hypothalamic pituitary axis, bile duct cells, ovarian ortesticu-
lar cells, salivary secretory cells, renal cells, chondrocytes, 
epithelial cells, nerve cells or progenitor cells. 
19. The method of claim 17 wherein the scaffold in the 
rotating bioreactor moves within the rotating bioreactor in a 
near circular particle trajectory. 
